+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Intuniv"

Intuniv - API Insight, 2022 - Product Thumbnail Image

Intuniv - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Intuniv- Drug Insight, 2019 - Product Thumbnail Image

Intuniv- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Intuniv is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. It is a non-stimulant medication that works by targeting the brain's neurotransmitters to reduce hyperactivity and impulsivity. Intuniv is usually prescribed in combination with other medications, such as stimulants, to help manage the symptoms of ADHD. It is available in both immediate-release and extended-release formulations. The Intuniv market is a subset of the larger mental disorders drugs market. It is a growing market, driven by the increasing prevalence of ADHD and the need for effective treatments. Intuniv is one of the most commonly prescribed medications for ADHD, and is used by both children and adults. Some companies in the Intuniv market include Shire Pharmaceuticals, Novartis, and Teva Pharmaceuticals. Show Less Read more